EPIRUS Biopharmaceuticals, Inc. Interest Payable, Current
EPIRUS Biopharmaceuticals, Inc. had Interest Payable, Current of $311.00 thousand as of 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2016-05-10
- 2016-03-31: Interest Payable, Current $311.00K.
- 2015-12-31: Interest Payable, Current $264.00K.
- 2015-09-30: Interest Payable, Current $213.00K.
- 2015-06-30: Interest Payable, Current $167.00K.
| Period end | Interest Payable, Current |
|---|---|
| 2016-03-31 | $311.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $264.00K 10-Q · filed 2016-05-10 |
| 2015-09-30 | $213.00K 10-Q · filed 2015-11-16 |
| 2015-06-30 | $167.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $90.00K 10-Q · filed 2015-05-13 |
| 2014-12-31 | $71.00K 10-K · filed 2016-03-29 |
| 2013-12-31 | $502.00K 10-K · filed 2015-03-31 |